Poland· PL-100474523
Scemblix
A asciminib product containing asciminibum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Asciminib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EA06 (asciminib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Asciminib · ATC L01EA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of asciminib costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.27 in France to $162.23 in Switzerland — a ×606 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Asciminib · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$162.23
- FR France$0.27
The record
At a glance
URPL (Poland)- Active substance
- Asciminibum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- L01EA06
- ATC class
- Asciminib
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin07613421131623
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Asciminib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSCEMBLIXNovartis Europharm Limited, Dublin
- SwitzerlandScemblix 40 mg, FilmtablettenNovartis Pharma Schweiz AG
- SpainSCEMBLIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- FinlandScemblixNovartis Europharm Limited
- FranceSCEMBLIX 40 mg, comprimés pelliculésNOVARTIS EUROPHARM (IRLANDE)
- IrelandScemblix 40 mg film-coated tabletsNovartis Europharm Limited
- IcelandScemblixNovartis Europharm Limited*
- NetherlandsScemblix 40mg, filmomhulde tabletNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scemblix
- Liechtenstein · Scemblix
- Norway · Scemblix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/abf39767-7d25-4793-9a89-da2ca0ec6866 GET /v1/drugs/abf39767-7d25-4793-9a89-da2ca0ec6866?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "40 mg",
"packaging": "Rpz ¦ EU/1/22/1670/003 ¦ 147190\n20 tabl.\n07613421131623 ¦ Rpz ¦ EU/1/22/1670/004 ¦ 147191\n60 tabl.\nRpz ¦ EU/1/22/1670/005 ¦ 160042\n180 tabl. (opakowanie zbiorcze) (3x60)",
"substance": "Asciminibum 40 mg",
"common_name": "Asciminibum",
"pl_product_id": "100474523",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about asciminib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.